Share Price | Creative Medical Technology Holdings, Inc. Stock Analysis & Recommendation

Q: How big is Creative Medical Technology Holdings, Inc.?

Market Cap: As of Jun 18, Creative Medical Technology Holdings, Inc. has a market capitalization of 5.79 million, classified as a Micro Cap.Recent Quarterly Performance: For the latest four quarters ending in March 2025, the company reported net sales of 0.01 million and a net profit of -6.09 million.Balance Sheet Snapshot: As of December 2024, the shareholder's funds amounted to 6.34 million, while total assets were reported at 6.67 million.

Q: What does Creative Medical Technology Holdings, Inc. do?

Overview: Creative Medical Technology Holdings, Inc. operates within the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.Financial Snapshot: Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025) Most recent Net Profit: -2 Million (Quarterly Results - Mar 2025) Market-cap: USD 5.79 Million (Micro Cap)Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -0.96 Return on Equity: -75.55% Price to Book: 0.72Contact Details: Registrar Address: Not available.

Q: Is Creative Medical Technology Holdings, Inc. technically bullish or bearish?

As of 28 August 2025, the technical trend for Creative Medical Technology Holdings, Inc. has changed from mildly bullish to bullish. The current stance is bullish, supported by a bullish MACD on the weekly timeframe, bullish Bollinger Bands on both weekly and monthly timeframes, and a bullish daily moving average. The KST is bullish weekly and mildly bullish monthly, while the OBV is bullish on both timeframes. The RSI shows no signals on both weekly and monthly timeframes.In terms of performance, the stock has returned 51.95% year-to-date, significantly outperforming the S&P 500's 12.22% return in the same period. However, over longer periods, the stock has underperformed the benchmark, with a 3-year return of -48.41% compared to the S&P 500's 70.41%.

Results Declared: Creative Medical Technology Holdings, Inc. has declared results on 20 Mar 2026! Click here to unlock the latest financial performance

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

4.75 k

Shareholding (Dec 2025)

FII

0.43%

Held by 4 FIIs

DII

97.68%

Held by 2 DIIs

Promoter

0.00%

How big is Creative Medical Technology Holdings, Inc.?

22-Jun-2025

As of Jun 18, Creative Medical Technology Holdings, Inc. has a market capitalization of 5.79 million and reported net sales of 0.01 million with a net profit of -6.09 million for the latest four quarters ending in March 2025. Shareholder's funds were 6.34 million, with total assets of 6.67 million as of December 2024.

View full answer

What does Creative Medical Technology Holdings, Inc. do?

22-Jun-2025

Creative Medical Technology Holdings, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $0 million and a net loss of $2 million as of March 2025. The company has a market cap of $5.79 million and key metrics indicate it is currently loss-making with a negative return on equity.

View full answer

Is Creative Medical Technology Holdings, Inc. technically bullish or bearish?

20-Sep-2025

As of August 28, 2025, Creative Medical Technology Holdings, Inc. has shifted to a bullish trend, supported by positive indicators across multiple timeframes, while year-to-date it has returned 51.95%, outperforming the S&P 500's 12.22%, though it has underperformed over three years with a return of -48.41% compared to the S&P 500's 70.41%.

View full answer

Compare Creative Medical Technology Holdings, Inc. with Similar Stocks

Seastar Medical Holding Corp.ENDRA Life Sciences, Inc.Navidea Biopharmaceuticals, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 7 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.96

Return on Equity

-106.61%

Price to Book

1.19

Revenue and Profits:

Net Sales:

0 Million

(Quarterly Results - Dec 2025)

Net Profit:

-2 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-15.77%

6 Months

-39.87%

1 Year

-29.17%

2 Years

-63.97%

3 Years

252.83%

4 Years

-94.23%

5 Years

-99.06%

Creative Medical Technology Holdings, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-2.75%

EBIT Growth (5y)

-227.94%

EBIT to Interest (avg)

-4.59

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.96

Sales to Capital Employed (avg)

0.00

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

12.31%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.19

EV to EBIT

-0.21

EV to EBITDA

-0.21

EV to Capital Employed

1.27

EV to Sales

1.27

PEG Ratio

Dividend Yield

ROCE (Latest)

-608.28%

ROE (Latest)

-106.61%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 2 Schemes (1.89%)

Foreign Institutions

Held by 4 Foreign Institutions (0.43%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Dec 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 0.00% vs -11.76% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.90",
          "val2": "-1.90",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.90",
          "val2": "-1.90",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-648,594.00%",
          "val2": "-628,578.00%",
          "chgp": "-2,001.60%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -9.09% vs -3.77% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-6.00",
          "val2": "-5.60",
          "chgp": "-7.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.00",
          "val2": "-5.50",
          "chgp": "-9.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,023,802.30%",
          "val2": "-522,169.20%",
          "chgp": "-50,163.31%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]